https://priyalifescience.com/article/menopause-diet-cancer-free-guide-second-edition-2026 Priya Life Science en 2026-11-04T17:00:01+00:00 Free Menopause After Cancer Diet Guide Gets Second Edition https://priyalifescience.com/article/northern-ireland-endometriosis-services-investment-2026 Priya Life Science en 2026-11-04T15:00:02+00:00 Northern Ireland Invests £1.95m in Endometriosis Services https://priyalifescience.com/article/amgen-fda-warning-letter-vectibix-promotional-video-2026 Priya Life Science en 2026-11-04T13:00:01+00:00 FDA Warning Letter Cites Amgen Vectibix Promotional Video https://priyalifescience.com/article/fda-inovio-voceryq-dna-immunotherapy-rrp-approval-2026 Priya Life Science en 2026-11-04T11:00:01+00:00 FDA Approves Inovio's Voceryq DNA Immunotherapy for RRP https://priyalifescience.com/article/fda-mounjaro-cardiovascular-risk-label-surpass-cvot-2026 Priya Life Science en 2026-11-04T08:30:02+00:00 FDA Heart-Risk Label for Mounjaro: What It Means for Ireland https://priyalifescience.com/article/fresenius-wuxi-biologics-biosimilars-agreement-37-candidates-2026 Priya Life Science en 2026-11-03T17:00:02+00:00 Fresenius and WuXi Biologics Sign 37-Biosimilar Deal https://priyalifescience.com/article/hpra-medsafetyweek-2026-report-side-effects Priya Life Science en 2026-11-03T15:00:03+00:00 MedSafetyWeek 2026: HPRA asks Ireland to report side effects https://priyalifescience.com/article/merck-lipfendra-oral-pcsk9-fda-eu-review-2026 Priya Life Science en 2026-11-03T13:00:02+00:00 Merck's Oral PCSK9 Pill Lipfendra: EU Review and Ireland https://priyalifescience.com/article/fda-tentative-approval-dr-reddys-generic-lenacapavir-2026 Priya Life Science en 2026-11-03T11:00:02+00:00 FDA Tentatively Approves Dr Reddy's Generic Lenacapavir https://priyalifescience.com/article/fda-approves-gsk-hibsago-bepirovirsen-hepatitis-b-2026 Priya Life Science en 2026-11-03T08:30:01+00:00 FDA Approves GSK's Hibsago for Chronic Hepatitis B in Adults